false
0001506929
0001506929
2026-11-17
2026-11-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) November 17, 2026 (November 13, 2026)
Verde Resources, Inc.
(Exact name of registrant as specified in its charter)
| Nevada |
|
000-55276 |
|
32-0457838 |
| (State
or other jurisdiction of |
|
(Commission |
|
(IRS
Employer |
| incorporation) |
|
File
Number) |
|
Identification
No.) |
7800 Forsyth Blvd., Suite 850, St. Louis, Missouri 63105
(Address of principal executive offices)
Registrant’s
telephone number, including area code (314) 530-9071
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| None |
|
None |
|
None |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this Chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this Chapter).
Emerging
Growth Company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers
CFO
Appointment
On
November 13, 2026, the board of directors (the “Board”) of Verde Resources, Inc. (the “Company”) appointed Michelle
Yanez as the Company’s Chief Financial Officer, effective November 16, 2026. The Company’s prior chief financial officer,
Sherina Chui, will take on the role of Senior Financial Controller commencing on November 16, 2026.
Ms.
Yanez has been a consultant to us regarding capital markets, finance and SEC compliance matters since March 2026. She is a senior financial
executive with over 25 years of experience in public and privately held biotech, pharmaceutical, and life science companies, and an additional
4 years’ experience in financial services and manufacturing companies. Ms. Yanez’ experience includes a broad range of responsibilities
in a highly complex and regulated market. She also brings deep corporate governance experience through her work with corporate boards,
including audit, compensation, nominating & governance and finance committees. Ms. Yanez is currently Co-Founder and CFO of Santander
Pharma Consulting, a privately held life sciences consulting firm that provides business development and commercial strategy services
to pharmaceutical, medical device, and life science companies offering guidance throughout all stages of commercial development, from
inception to product launch, since February 2024. Ms. Yanez previously served as the CFO of MIRA Pharmaceuticals (Nasdaq: MIRA) from
April 2023 to June 2025, and from June 2024-June 2025, she also served as CFO of Telomir Pharmaceuticals (Nasdaq: TELO). Both companies
were publicly traded clinical-stage pharmaceutical development companies. Ms. Yanez also serves as a non-employee director of Inhibitor
Therapeutics, Inc. (OTCQB: INTI), a publicly traded pharmaceutical development company focused on therapeutics for certain cancers and
non-cancerous proliferation disorders, since December 2022. Ms. Yanez earned her B.A. in Business Management from University South Florida
and an MBA in Strategic Leadership from Rutgers School of Business, Cum Laude.
There
is no arrangement or understanding between Ms. Yanez and any other person pursuant to which Ms. Yanez was selected as an officer, and
Ms. Yanez is not a party to, and does not have any direct or indirect material interest in, any transaction requiring disclosure under
Item 404(a) of Regulation S-K. There is no family relationship between Ms. Yanez and any director or executive officer of the Company.
CFO
Agreement
On
November 14, 2026, in connection with the appointment of Ms. Yanez as Chief Financial Officer, the Company entered into an employment
offer letter (the “CFO Agreement”) with Michelle Yanez, commencing as of November 16, 2026, providing for the terms pursuant
to which Ms. Yanez will serve as Chief Financial Officer of the Company. Pursuant to the CFO Agreement, Ms. Yanez will receive a base
salary of $225,000 per annum, and receive a one-time grant of the Company’s common stock valued at $25,000. Ms. Yanez will also
be eligible for annual performance-based cash bonuses and equity incentive awards, subject to the discretion and approval of the Board,
and will be eligible to participate in all employee benefit plans and programs (including medical and dental insurance) made available
by the Company from time to time to similarly situated senior executives.
The
CFO Agreement will have an initial term of two years, however the CFO Agreement is at will, and either party to the agreement may terminate
it at any time, however in the case of resignation, Ms. Yanez will give at least thirty (30) days’ prior written notice. In the
case of Termination without Cause (as defined in the CFO Agreement), or resignation for Good Reason (as defined in the CFO Agreement),
Ms. Yanez will be entitled to certain severance benefits. Pursuant to the Employment Agreement, Ms. Yanez agreed to be bound by certain
covenants, including confidentiality, non-solicitation, non-competition, and other standard covenants contained therein.
In
connection with the entry into the CFO Agreement, the services agreement between the Company and Ms. Yanez dated March 1, 2026 (the “Services
Agreement”) was automatically terminated on the effective date of the CFO Agreement, and in connection with the termination of
the prior Services Agreement, the Company agreed to pay Ms. Yanez through the issuance of shares of common stock of the Company valued
at $40,375 for services rendered under the Services Agreement through November 15, 2026.
The
foregoing description of Employment Agreement is qualified in its entirety by reference to the text of such agreement, which is filed
as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits
The
following exhibits are being filed herewith:
| Exhibit
No. |
|
Description |
| 10.1 |
|
Employment Offer Letter, dated November 14, 2026, between the Company and Michelle Yanez |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL documents) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
Verde
Resources, Inc. |
| |
|
|
| |
By: |
/s/
Jack Wong |
| |
Name: |
Jack
Wong |
| |
Title: |
Chief
Executive Officer |
| |
|
|
| Dated:
November 17, 2026 |
|
|